Showing results (61-70 of 533) with videos related to
Sort By:
Pageof 54
Blood|September 9, 2006
Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?Krzysztof Mrózek, Guido Marcucci, Peter Paschka, et al.Best Practice & Research. Clinical Haematology|August 25, 2009
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemiasGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemiaRebecca B Klisovic, William Blum, Xiaohui Wei, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 23, 2005
Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometryGuowei Dai, Xiaohui Wei, Zhongfa Liu, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 14, 2009
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignanciesMehdi Hamadani, William Blum, Gary Phillips, et al.Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|March 12, 2002
Leukocytoreduction for acute leukemiaPierluigi Porcu, Sherif Farag, Guido Marcucci, et al.BMC Genomics|November 9, 2012
Methods for high-throughput MethylCap-Seq data analysisBenjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.The Journal of Clinical Investigation|February 16, 2016
Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cellsBin Zhang, Ling Li, Yinwei Ho, et al.Rapid Communications in Mass Spectrometry : RCM|March 9, 2006
Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification methodZhongfa Liu, Guido Marcucci, John C Byrd, et al.Research Square|January 30, 2023
Human ILC1s target leukemia stem cells and control development of AMLMichael Caligiuri, Zhenlong Li, Rui Ma, et al.Pageof 54